Northern Nanotechnologies MSDS Pb Cr O 4 rev 1 0 Page 2
Potential Health Effects:
No health effects have been determined for nanocrystalline forms of this material.
We recommend appropriate precautions be taken to limit exposure to this
material.
Inhalation: No data available.
Skin contact: No data available.
Eye contact: No data available.
Ingestion: No data available.
Carcinogen status:
Lead chromate:
OSHA: Yes (Z)
NTP: Yes (known)
IARC: Yes: 2A (as lead compounds); 1 (as lead chromate)
Section 4 First Aid Measures
First Aid:
Eye contact: If this chemical gets into the eyes, remove any contact lenses at
once and irrigate immediately for at least 15 minutes, occasionally lifting upper
and lower lids. Seek medical attention immediately.
Skin contact: If this chemical contacts the skin, remove contaminated clothing
and wash immediately with soap and water. Seek medical attention immediately.
Inhalation: If this chemical has been inhaled, remove from exposure, begin
rescue breathing (using universal precautions) if breathing has stopped and CPR
if heart action has stopped. Transfer promptly to a medical facility.
Ingestion: When this chemical has been swallowed, get medical attention. Give
large quantities of water and induce vomiting. Do not make an unconscious
person vomit.
Antidotes and Special procedures for lead: Persons with significant lead
poisoning are sometimes treated with Ca EDTA while hospitalized. This
"chelating" drug causes a rush of lead from the body organs into the blood and
kidneys and thus has its own hazards, and must be administered only by highly
experienced medical personnel under controlled conditions and careful
observation. Ca EDTA or similar drugs should never be used to prevent
Northern Nanotechnologies Inc., 700 Bay St., Suite 1100, Toronto, ON M5G 1Z6 Tel (416) 260-8889 Fax (416) 260-8839
